Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck ...

When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non ...

For lung cancer, Opdivo is typically taken in combination with ipilimumab, and sometimes with chemotherapy made from platinum. Note: After the Food and Drug Administration (FDA) approves a ...

GSK Plc and iTeos Therapeutics ended the development of an experimental lung cancer drug, the latest in a series of setbacks ...

US FDA Approves AbbVie's Drug for a Type of Lung Cancer (Reuters) -The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression, the agency announced Wednesday. The approval was based on results from the phase II LUMINOSITY ...